Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
80 participants
INTERVENTIONAL
2012-08-17
2016-02-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This trial is designed as a parallel armed randomized controlled trial.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hypothermic Oxygenated Perfusion (HOPE) of Human Liver Grafts
NCT01317342
Abdominal Regional Perfusion in Donation After Cardiac Death for Multi-Organ Transplantation
NCT03946852
Remote Ischemic Preconditioning and Acute Kidney Injury in HTX
NCT05364333
Predictive Accuracy of Machine Perfusion for Kidney Transplant Outcomes in Germany
NCT07348874
The Effect of Remote Ischemic Preconditioning on Ischemia/Reperfusion Injury in a Liver Transplant Recipient
NCT03758352
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AP-KTx/LTx
Transplant recipients receiving an rATG-perfused kidney or liver
organ perfusion with rabbit anti-thymocyte globulin (rATG)
CP-KTx/LTx
Transplant recipients receiving a control-perfused kidney or liver.
organ perfusion with saline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
organ perfusion with rabbit anti-thymocyte globulin (rATG)
organ perfusion with saline
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University Innsbruck
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Katja Kotsch
Univ. Prof. Dr. Katja Kotsch
References
Explore related publications, articles, or registry entries linked to this study.
Ritschl PV, Gunther J, Hofhansel L, Kuhl AA, Sattler A, Ernst S, Friedersdorff F, Ebner S, Weiss S, Bosmuller C, Weissenbacher A, Oberhuber R, Cardini B, Ollinger R, Schneeberger S, Biebl M, Denecke C, Margreiter C, Resch T, Aigner F, Maglione M, Pratschke J, Kotsch K. Graft Pre-conditioning by Peri-Operative Perfusion of Kidney Allografts With Rabbit Anti-human T-lymphocyte Globulin Results in Improved Kidney Graft Function in the Early Post-transplantation Period-a Prospective, Randomized Placebo-Controlled Trial. Front Immunol. 2018 Aug 24;9:1911. doi: 10.3389/fimmu.2018.01911. eCollection 2018.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UN4640
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.